SciELO - Scientific Electronic Library Online

 
vol.21 issue1Safety and efficacy of ivermectin in times of COVID-19Type 3c diabetes mellitus secondary to chronic pancreatitis: a case report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Horizonte Médico (Lima)

Print version ISSN 1727-558X

Abstract

PUMAPILLO GARCIA, Ana Sarai  and  QUISPE CASTILLO, Carmen Zaira. COVID-19 treatment guidelines in adults. Horiz. Med. [online]. 2021, vol.21, n.1, e1362. ISSN 1727-558X.  http://dx.doi.org/10.24265/horizmed.2021.v21n1.11.

A novel coronavirus disease called COVID-19 was discovered as a result of the outbreak that began in China at the end of December 2019. Common symptoms are fever, dry cough, shortness of breath and malaise. Several research are being conducted since the disease has high transmission rate even though it is not considered life-threatening. However, together with hospital and out-of-hospital care, there is a group of medications being used to fight this disease, such as hydroxychloroquine, chloroquine, remdesivir, lopinavir/ritonavir, tocilizumab, interferon beta-1b, among others.

Keywords : Coronavirus infections; Treatment; Drug administration schedule; Respiratory distress syndrome, adult; Severe acute respiratory syndrome; Pneumonia; Sepsis; Shock, septic.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )